Workflow
中国化学(601117):化工及实业板块经营稳健,境外营收增长亮眼
CNCECCNCEC(SH:601117) EBSCN·2025-09-01 11:49

Investment Rating - The report maintains a "Buy" rating for the company [1]. Core Views - The chemical and industrial sectors are operating steadily, with significant growth in overseas revenue [1]. - The company achieved a total revenue of 907.2 billion yuan in H1 2025, with a slight year-on-year decrease of 0.3%, while net profit attributable to shareholders increased by 9.3% to 31.0 billion yuan [4][6]. - The company plans to distribute a cash dividend of 1.0 yuan per 10 shares, representing a payout ratio of 19.7% [4]. Revenue Performance - In H1 2025, the company signed new contracts worth 2060.9 billion yuan, a year-on-year increase of 1.2%, with domestic and overseas contracts amounting to 1646.1 billion yuan and 414.8 billion yuan, respectively [5]. - The chemical engineering sector saw new contracts exceed 1600 billion yuan for the first time in H1 2025, with significant contributions from major projects [5]. Profitability and Financial Metrics - The company's gross margin improved to 9.6% in H1 2025, with a net margin of 3.7%, reflecting a year-on-year increase of 0.2 and 0.3 percentage points, respectively [7]. - The company reported a net cash flow from operating activities of -100.3 billion yuan, with a significant improvement in Q2, where net cash inflow reached 50.6 billion yuan [7]. Future Growth Potential - The rapid development of the coal chemical industry in Xinjiang is expected to boost the company's performance, with potential market share gains in key technology areas [8]. - The company is positioned to benefit from rising chemical product prices due to its initiatives against price competition [8]. Earnings Forecast and Valuation - The company’s net profit forecasts for 2025-2027 are maintained at 64.3 billion yuan, 68.9 billion yuan, and 73.5 billion yuan, respectively [9]. - The report provides a detailed earnings forecast, projecting revenue growth rates and profit margins for the coming years [10][11].